Prometheus Laboratories Announces Partnership with Takeda to Launch CDPATH™, a Personalized Prognostic Tool Advancing Innovation for Crohn’s Disease Patients
News & Events [...]
Prometheus Laboratories Announces the Launch of PredictrPK® IFX, A Revolutionary Test Enabling Precision-Guided Dosing for Inflammatory Bowel Disease
News & Events [...]
Prometheus Laboratories Announces New Agreement with MultiPlan, Expanding Patient Access to Specialized GI Testing
News & Events [...]
Prometheus Laboratories Announces Multiple Presentations on Precision-Guided Dosing and Monitoring at the Digestive Disease Week 2021 Annual Meeting
News & Events [...]